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A B S T R A C T
Hepatocyte growth factor (HGF) is a most potent hepatocyte mitogen, and plays a
mayor role in liver regeneration during injury. The aim of this study was to evaluate
HGF values in Croatian healthy and alcoholic liver cirrhosis patients (AC). The HGF
and standard laboratory tests of liver damage were measured in 33 AC patients, and 41
healthy subjects. HGF was measured by using an ELISA method. The HGF levels were
higher in cirrhotic patients than in healthy subjects (median value is 0.78 vs. 0.19 ng/ml,
p < 0.001). Japanese study showed similar values of HGF for healthy subjects and AC
subjects. The HGF values in patients depend on grade of illness. There was found sig-
nificant correlation between HGF and almost all standard liver damage tests. The ROC
analysis showed that measuring of HGF had convincingly best accuracy than other pa-
rameters, and seems to be useful in classifying grade of illness.
Introduction
Alcohol consumption causes not only
psycho-social problems but also many or-
gan diseases among which liver cirrhosis
is most usual1,2. One of the latest signifi-
cant developments has been the purifica-
tion and characterization of hepatocyte
growth factor, a multifunctional cytokine
greatly released from Ito, but also from
many other cell types, such as Kupffer,
endothelial and lung fibroblasts3. HGF has
morphogenic, mitogenic and angiogenic ac-
tivities, and one of its fundamental role is
effect on liver growth and development3,4.
HGF is a species non-specific heterodi-
mer with molecular weight of 105 kD and
consists of two polypeptide chains,  with
38 kD, and  with 68 kD, linked together
by disulfide bonds5. In humans HGF gene
is localized on chromosome 7 and com-
posed of 18 exons and 17 introns, spans
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approximately 70 kb3. Receptor for HGF
(Met-protein), has the configuration of a
type II tyrosine kinase receptor, and con-
sists of an  chain (50 kDa) which re-
mains entirely extracellular, and a large
polypeptide chain (145 kDa)6–8. It is ex-
pressed in normal epithelium of almost
every tissue and a variety of tumor cell
lines. The gene coding receptor is the
c-met protooncogen and is also localized
on chromosome 77. The regeneration pro-
cess in the liver causes activation of HGF
gene resulted by releasing inactive pre-
cursor pro-HGF which is bio-activated by
proteolytic digestion8. During the liver
regeneration increased HGF levels were
found in sera of liver disease patients cor-
relating with the severity of liver damage
and histological activity index score, so
could be a good marker of degree of liver
damage9,10. The aim of this study was to
evaluate HGF values in healthy and alco-
holic liver cirrhosis patients in north
Croatia as well as to investigate clinical
significance of HGF measurement in pa-
tients with various degrees of illness.
Materials and Methods
Subjects
Thirty-three patients with clinical and
laboratory evidence of alcoholic cirrhosis
and 41 sex and age matched healthy sub-
jects were included in the study. Inclusion
criteria for patients were: > 80 g of alco-
hol ingested daily during a period of at
least five years, absence of clinical evi-
dence of other diseases or therapy with
steroids or cytostatics, and negative hep-
atitis B and C virus serology. The degree
of liver injury was determined according
to Child-Turcot classification and pati-
ents divided into three groups (Child A,
N = 10, and Child B, N = 9, Child C,
N = 14). Venous blood-samples for HGF,
total bilirubin, AST, ALT,  GT, AP, albu-
min determination and other analyses
were measured at the same morning. Se-
rum for determination of HGF levels was
stored at –20 °C.
Methods
Total bilirubin, AST, ALT,  GT, AP and
albumin levels were measured by pro-
posed or reference IFCC method on 30 °C
on Synchron CX4, Beckman and Spec-
trum, Abbott. Serum immunoglobulin le-
vels were measured by electroimmuno-
diffusion, whereas prothrombin index by
the one-stage method (Quick).
The concentration of HGF was mea-
sured by ELISA »sandwich« enzyme im-
munoassay (Otsuka Pharmaceuticals Co,
Tokyo, Japan). Briefly, samples and stan-
dards dispensed into a 96 wells microtiter
plate coated with a monoclonal antibody
against human HGF were incubated for 1
h, and washed three times. After washing
anti-h-HGF rabbit serum (h-HGF anti-
body) is added and after incubation was-
hed away. After the addition of anti-
-rabbit IgG (HRP conjugate anti-rabbit
IgG marked by enzyme) the plate was in-
cubated for 1 h, then washed three times.
An aliquot (0.1 ml) of 0.25% o-phenyl-
enediamine (OPD) was added as a sub-
strate and the plate allowed to stand for
10 min. After the reaction was stopped by
the addition of 0.1 ml of 1 N sulphuric
acid, the absorbency was measured at
492 nm by an automated plate reader
with a reference wavelength of 690 nm.
The detection limit of this assay is 0.1
ng/ml and normal range is less than 0.34
ng/ml10.
Statistical analysis
Kruskal-Wallis one way analysis of
variance on ranks was used to compare
the means obtained in four groups. Mann-
-Whitney test was used for testing differ-
ences between whole patient group and
healthy subjects. The linear and polyno-
mial regression analysis was used to test
correlation between parameters. To test
the diagnostic accuracy of each liver func-
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tion test and the HGF levels the receiver
operator curve analysis (ROC) was done.
All statistic analyses were made by the
computer program Excel Version 7.0 and
SigmaStat. Jandel. Version 2.0.
Results
The medians and range of HGF values
in healthy subjects and groups of cir-
rhotic patients are presented in Figure 1.
The HGF levels were significantly increa-
sed in the whole group of patients when
compared with healthy subjects. The medi-
an of whole cirrhotic group was 0.78ng/ml
vs. 0.19 ng/ml in healthy subjects (p < 0.001,
Mann-Whitney test).
Statistically significant differences
were also found comparing the median
values of HGF in patients subgroups and
healthy subjects: HGF median value was
0.44 ng/ml in Child A, 0.68 ng/ml in Child
B and 1.02 ng/ml in Child C vs. 0.19
ng/ml in healthy volunteers, (p < 0.001,
Kruskal-Wallis test).
There was found statistically signifi-
cant difference between subgroups at self,
too (p < 0.001, Kruskal-Wallis test). The
values of other biochemical markers of
liver damage in patient group as a whole,
and in healthy subjects are presented in
Table 1. Albumin were significantly lower
in the patients (p < 0.001), suggesting a
decrease in the liver capacity to synthe-
size proteins on the one hand, and prov-
ing the loss of albumin in the ascitic fluid
of all patient groups. The median values
of AP, AST, ALT and  GT showed signifi-
cantly higher values in the patients com-
pared to healthy subjects (p < 0.001). The
values of other biochemical markers of
liver damage in patient subgroups and
healthy subjects are presented in Table 2.
There was found a significant difference
between the mean values of the same
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Fig. 1. HGF in healthy subjects and subgroups
of patients presented as median and range.
Statistically significant difference was found
between each subgroup and healthy subjects
and between subgroups, too (p < 0.001, Kruskal
-Wallis test).
TABLE 1
BIOCHEMICAL MARKERS (MEDIAN VALUES) OF LIVER DAMAGE IN ALCOHOLIC CIRRHOSIS PA-
TIENTS AND HEALTHY SUBJECTS
Test Healthy subjects (N = 41) Patients (N = 33)
HGF (ng/ml) 0.19 0.78*
Albumin (g/l) 40.4 26.4*
Immunoglobulins (g/l) 19.5 33.4*
Bilirubin ( mol/l) 17.0 80.6*
AP (IU/l) 48 81*
AST (IU/l) 11 47*
ALT (IU/l) 13 37*
 GT (IU/l) 9 52*
* p < 0.001, Mann-Whitney test, patients vs. healthy subjects.
liver damage tests in the healthy subjects
and either study subgroup, p < 0.001, Krus-
kal-Wallis one-way analysis on ranks.
Correlations between the tested
parameters
A statistically significant (p < 0.01)
positive linear correlation was found be-
tween HGF levels and AST, ALT,  GT, bil-
irubin, AP, immunoglobulins and IgA of
all tested subjects. These correlations and
regression lines are shown in Figure 2.
A statistically significant nonlinear
correlation with a regression line of the
polynomial type was found between HGF
levels and serum albumin (r = –0.79,
p < 0.01) (Figure 2). Prothrombine index
was measured only in patients and a sta-
tistically significant nonlinear correlation
with a regression line of the polynomial
type was found between HGF levels and
prothrombine index in patient group
(r = –0.53, p < 0.01). This correlation and
regression line of polynomial type are
shown in Figure 2.
ROC analysis
In order to evaluate diagnostic accu-
racy of performed tests the ROC analysis
was done (Figure 3). The area (S) under
ROC has been advocated as a measure of
diagnostic value of each test. A curve
with upward deviation toward the left
corner denotes better test. ROC analysis
also allows selection of the best cut-off
point for each test, i.e. the point yielding
the lowest proportion of false negative
and false positive results. As shown in
Figure 3, HGF is convincingly the best
marker of liver lesion, and its diagnostic
accuracy is near by 100%. The best cut-off
HGF value is 0.37 ng/ml. Another excel-
lent markers are bilirubin, serum albu-
min and immunoglobulins, whereas AST,
ALT and  GT have limited value in dis-
crimination between liver cirrhosis pa-
tients and healthy subjects. On the con-
trary, AP is not of choice in testing liver
cirrhosis because a low diagnostic accu-
racy.
Discussion
The main purpose of this study was to
evaluate HGF values in healthy and alco-
holic liver cirrhosis patients in north Cro-
atia. The median value of HGF in healthy
subjects was 0.19 ng/ml (range 0.12–0.38),
what is similar to data given by Tsubo-
uchi et al. (0.24  0.12 ng/ml)10 and Hioki
et al. (0.19  0.06 ng/ml)11. According to
Hillan upper limit for healthy subjects is
0.5 ng/ml12. Mean values obtained in Jap-
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TABLE 2
BIOCHEMICAL MARKERS (MEDIAN VALUES) OF LIVER DAMAGE IN ALCOHOLIC CIRRHOSIS










Albumin (g/l) 40.4 30.1* 30.1* 23.3*
Immunoglobulins (g/l) 19.5 23.5* 32.7* 43.5*
Bilirubin ( mol/l) 17.0 38.9* 43.0* 92.0*
AP (IU/l) 48 84* 77* 78*
AST (IU/l) 11 24* 50* 52*
ALT (IU/l) 13 41* 30* 38*
 GT (IU/l) 9 95* 26* 50*
* p < 0.001, difference between each subgroup and healthy subjects, Kruskal-Wallis one-way
analysis on ranks.
anese AC subjects were 0.43  0.16 and
in another study mean was 0.71 ng/ml9,11.
In our study HGF median value in pa-
tient group was 0.78 ng/ml. Another aim
was to investigate clinical significance of
measuring HGF levels in alcoholic cirrho-
tic patients with various degree of liver
failure. When we compared HGF levels
according to modified Child classification
of patients we found higher levels in
Child C subgroup than in Child B or
Child A, what suggests a correlation be-
tween the degree of liver injury and/or re-
generation with HGF elevation. It could
be a good early marker of hepatocyte re-
generation during active phase of liver
cirrhosis.
Histologic findings of liver biopsies are
used for prognosis in patients with liver
disease13,14. The degree of HGF elevation
is also useful to differentiate fulminant
and chronic types of hepatic failure10. Shi-
ota also found positive correlation between
HGF levels and histological activity index
score (HAI), and especially with fibrosis,
so HGF elevation may reflect liver necro-
sis and activity of liver regeneration9. In
the study done by Hillan et al. authors
found positive correlation between HGF
levels and hepatocyte proliferation in li-
ver biopsies of alcoholic hepatitis pati-
ents12. Positive correlation between HGF
mRNA levels and indices of hepatocyte
proliferation was found in acute and
chronic liver disease patients11. In an-
other study performed in patients with
primary biliary cirrhosis HGF levels were
higher than in healthy subjects, but
levels did not correlate with indices of
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Fig. 2. The correlations between HGF levels and other liver damage tests in subjects presented at xy
scatter diagrams with lines of regression and equations, p < 0.01.
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Fig. 3. The ROC analysis for performed tests shows the ability of each test to discriminate
liver cirrhosis patients from healthy subjects. S = area under curve which represents
ability to discriminate liver cirrhosis patient from healthy subjects.
hepatocyte proliferation12. This is caused,
probably, by differences in ethiopatho-
genesis of that kind of cirrhosis. Accord-
ing to results of Appasamy elevation of
HGF during liver regeneration is caused
by decreased hepatic clearance on the one
hand and by enhanced production, main-
ly in Ito cells, on another hand. In pa-
tients with hepato-renal dysfunction it
could be a result of decreased renal filtra-
tion and elimination8.
The results of our study also showed
that HGF has the best diagnostic accu-
racy in discriminating healthy from liver
cirrhosis patients, than any other stan-
dard liver function test, where near by
100% patients had true positive and 100%
healthy subjects had true negative HGF
levels (best cut-off is 0.37 ng/ml). Other
standard liver damage tests like serum
albumin, AST, ALT,  GT, bilirubin and
immunoglobulins, have also high efficacy.
The role of elevated IgA is well known in
liver cirrhosis patients15. On the contrary
the AP value is not good marker of that
kind of liver disease. Elevated AP in alco-
holic liver cirrhosis patients could be a re-
sult of other changes such as concomitant
biliary stasis in cirrhotic liver. Some au-
thors represented a result of a long-term
HGF monitoring in liver diseases. They
found that persisting of elevated HGF is
a bad prognostic sign and usually is re-
corded in patients who died within 6
months. Patients who recovered had a
slight declination of HGF levels and that
can be good prognostic sign16,17. We did
not monitor HGF level changes during a
such period, but six patients in group
Child B or C died within 6 months after
HGF measurement, while none of pati-
ents died in Child A, what also supports
thesis that lower HGF levels are good
prognostic sign in alcoholic liver cirrho-
sis. Some authors suggest measuring
HGF levels as index of catabolism of pati-
ents awaiting liver transplantation18. The
significance of this growth factor is in pa-
tients after hepato-biliary resection19. In
animal models there was found that HGF
prevents fulminant hepatic failure and
inhibits massive hepatocyte apoptosis20.
It is obvious that further investigations of
HGF functions are required in liver dis-
ease patients. In conclusion, we confir-
med that elevated HGF as a result of
liver disease seems to be useful in grad-
ing alcoholic liver cirrhosis patients as
well as in cases when there are some
doubts about disease activity.
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RAZINE HEPATOCITNOG ^INITELJA RASTA U BOLESNIKA S
ALKOHOLNOM CIROZOM JETRE TE U ZDRAVIH ISPITANIKA IZ
HRVATSKE
S A @ E T A K
Hepatocitni ~initelj rasta (engl. skra}enica HGF) je najja~i mitogen za hepatocite s
va`nim u~inkom za vrijeme regeneracije jetre. Cilj rada je bio odre|ivanje vrijednosti
HGF u bolesnika s alkoholnom cirozom jetre (AC) i zdravih ispitanika u sjevernoj
Hrvatskoj. HGF i uobi~ajeni biljezi o{te}enja jetre mjereni su u 33 bolesnika i 41 zdra-
vog ispitanika. HGF je mjeren primjenom ELISA testa. Vrijednosti HGF su bile ve}e u
bolesnika nego u zdravih ispitanika (medijan 0.78 u odnosu na 0.19 ng/ml, p < 0.001).
U radu japanskih autora sli~ne vrijednosti su dobivene za zdrave i bolesne ispitanike.
Vrijednosti HGF-a u bolesnika su ovisne o te`ini bolesti. Dobivena je zna~ajna kore-
lacija izme|u HGF i gotovo svih standardnih biljega. Prema rezultatima ROC analize
HGF ima uvjerljivo najbolju klini~ku valjanost u usporedbi s ostalim pokazateljima,
stoga se ~ini pogodnim biljegom za odre|ivanje stupnja bolesti.
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